Compare PCTY & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCTY | TECH |
|---|---|---|
| Founded | 1997 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.5B |
| IPO Year | 2014 | 1989 |
| Metric | PCTY | TECH |
|---|---|---|
| Price | $152.46 | $58.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 14 |
| Target Price | ★ $206.82 | $71.23 |
| AVG Volume (30 Days) | 582.0K | ★ 1.9M |
| Earning Date | 02-05-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.55% |
| EPS Growth | ★ 2.58 | N/A |
| EPS | ★ 4.00 | 0.49 |
| Revenue | ★ $1,640,437,000.00 | $1,216,732,000.00 |
| Revenue This Year | $10.20 | $2.33 |
| Revenue Next Year | $8.59 | $7.05 |
| P/E Ratio | ★ $38.20 | $119.71 |
| Revenue Growth | ★ 13.30 | 3.85 |
| 52 Week Low | $135.46 | $46.01 |
| 52 Week High | $223.80 | $79.28 |
| Indicator | PCTY | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 60.42 | 42.98 |
| Support Level | $148.81 | $56.84 |
| Resistance Level | $154.99 | $61.20 |
| Average True Range (ATR) | 3.32 | 2.01 |
| MACD | 0.74 | -0.53 |
| Stochastic Oscillator | 76.15 | 18.93 |
Founded in 1997, Paylocity is a cloud-based human capital management and payroll platform servicing midmarket customers. The company's average client size is around 150 employees. Its products help with recruiting and onboarding, payroll, time and labor, human resources, benefits, learning, and performance and compensation workflows. In fiscal 2025, the company generated over $1.5 billion in revenue across more than 41,000 customers.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.